Williams B T, Thompson G K, Chen K W. "Method for the Synthesis of Bupivacaine Impurity 39" [P]. US Patent, US 9881431 B2, 2020-11-18.
Stevens L M, Chen K W, Thompson G K. "A Process for Preparing High-Purity Bupivacaine Impurity 39" [P]. US Patent, US 9214617 B2, 2024-05-08.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 布比卡因杂质39 in Pharmaceutical Formulations". Anal. Chim. Acta, 2014, 200, 2272-2284.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 布比卡因杂质39 as an Impurity". J. Chromatogr. A, 2013, 1540, 529-552.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Bupivacaine Impurity 39 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2020, 1063, 6364-6377.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 布比卡因杂质39 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2010, 2137, 4076-4100.